Home > Journals > Medicine > European Journal of Dermatology > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version
  Version PDF

Brachioradial pruritus: report of a new case responding to gabapentin


European Journal of Dermatology. Volume 16, Number 3, May-June 2006, Correspondence



Author(s) : Jean Kanitakis, Dept. of Dermatology Ed. Herriot Hospital (Pav. R) 69437ÂLyon cx 03, France.

ARTICLE

Auteur(s) : Jean KANITAKIS

Dept. of Dermatology Ed. Herriot Hospital (Pav. R) 69437 Lyon cx 03, France
<jean.kanitakis@chu-lyon.fr>

Brachioradial pruritus (BRP) is an enigmatic dermatosis characterized by persistent burning or stinging itch of the skin over the brachioradialis muscles. It was first reported in 1968 under the term «solar pruritus». Whereas chronic sun exposure has been considered to be the main cause of this disease [1,2], several recent reports suggest that BRP may be a manifestation of neuropathic pruritus, linked to spinal cord disease causing impingement of spinal nerves [3, 4]. The treatment of BRP is not well established. A new patient with BRP successfully treated with gabapentin is reported herein.
A 54-year-old white man complained of severe, burning pruritus of two years’ duration localized to the neck, shoulders and the posterior-external aspect of both arms, spreading down to the elbows and the upper part of the forearms. Pruritus was intractable and worsened at night, waking the patient. Before visiting our department, the patient had consulted a dermatologist and tried various treatments, including oral antihistamines and creams, but these proved ineffective. Significant sun exposure was denied; moreover, the symptoms had no obvious relation with the summer season. Two skin biopsies taken from the arm had shown nonspecific findings consistent with a lesion induced by scratching. Routine laboratory workup (including CRP, transaminases, creatinin, IgE dosage) was within normal limits (except for slightly raised gamma-GT values). The patient’s past medical history was unremarkable (with the exception of surgery for biliary lithiasis). Traumatism to the spine or neck was not recalled. Clinically, the skin was unremarkable, save for the presence of sparse minute papular-follicular lesions due to scratching. On the basis of these findings, the diagnosis of BRP was made. X-ray examination showed sagittal rectitude of the spine with protrusive codiscarthrosis at the C5C6 and C6C7 levels.
Because of the inefficacy of previous treartments, the patient was given, after informed consent, treatment with oral gabapentin, starting with 300 mg/d, increased to 3 ×  400 mg/d over two months. This resulted in improvement of the pruritus, namely over the neck. Gabapentin was further increased to 3 ×  600 mg/d; after two months, no further improvement was achieved, and the patient complained of diarrhea and sleepiness. After an additional two-month treatment, associated with an antipruritic cream containing 8% calamine and essential fatty acids, the patient reported significant (90%) improvement of pruritus; he could lead a normal life and sleep comfortably at night. Over the next two months he voluntarily decreased the treatment to 1200 and 600 mg/d before discontinuing it completely; pruritus developed again on the shoulders within a few days, although it was less severe. Gabapentin was increased to 1800 mg\d and the symptoms improved again. The patient was lost to further follow-up.
BRP is rarely reported in the literature, but is probably under-recognized. Its pathogenesis remains unclear. Both solar radiation and cervical neuropathy have been incriminated. Very recently, familial cases have been reported, inherited probably in an X-linked, recessive pattern [5]. Treatment of BRP is difficult and not standardized. Capsaicin cream has reportedly given good results in some patients, but a controlled study failed to confirm this [1]. Sun protection, amitryptiline, acupuncture, cervical spine manipulation and application of ice packs or cold towels may produce relief. Gabapentin (C9H17NO2) is a novel agent that has been used successfully in the treatment of neuralgias (including postherpetic neuralgia and allodynia), neuropathies and various itching conditions, including uremic pruritus and BRP [6]. Its mechanism of action is unknown, although potentiation of inhibitory GABAergic transmission may be relevant. The effect of gabapentin on our patient’s pruritus was obvious, since its intensity wasclearly related to treatment. This observation further highlights BRP as an expression of neuropathic pruritus, and upholds the usefulness of gabapentin for its treatment. n

1. Wallengren J. Brachioradial pruritus: a recurrent solar dermopathy. J Am Acad Dermatol 1998; 39: 803-6.

2. Wallengren J, Sundler F. Brachioradial pruritus is associated with a reduction in cutaneous innervation that normalizes during the symptom-free remissions. J Am Acad Dermatol 2005; 52: 142 -5.

3. Cohen AD, Masalha R, Medvedovsky E, Vardy DA. Brachioradial pruritus: a symptom of neuropathy. J Am Acad Dermatol 2003; 48: 825-8.

4. Goodkin R, Wingard E, Bernhard JD. Brachioradial pruritus: cervical spine disease and neurogenic\neuropathic pruritus. J Am Acad Dermatol 2003; 48: 521-4.

5. Wallengren J, Dahlenbeck K. Familial brachioradial pruritus. Br J Dermatol 2005; 153: 1016-8.

6. Winhoven S, Coulson I, Bottomley W. Brachioradial pruritus: response to treatment with gabapentin. Br J Dermatol 2004; 150: 786-7.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]